Global oncology nutrition market, forecast to 2023

Page 1

Global Oncology Nutrition Market


Summary  Oncology nutrition market is projected to grow at a CAGR of 8.7% between 2018 and 2023  The oncology nutrition market is expected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%.  The overall growth of the market is largely driven by the shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions.  The development of elemental formulas and product innovation in this field also provides significant growth opportunities in this market.



Based on cancer type, the oncology nutrition market is segmented into        

Head & Neck Cancers Stomach & Gastrointestinal Cancers Pancreatic Cancer Liver Cancer Esophageal Cancer Lung Cancer Breast Cancer Blood Cancer


Key Players Top Players

Emerging Players

 Abbott Laboratories (US)

 Mead Johnson Nutrition Company (US)

 Nestle S.A. (Switzerland)

 Hormel Foods (US)

 Danone (France)

 Meiji Holdings (Japan)

 Fresenius Kabi AG (Germany)

 Victus (US)

 B.Braun Melsungen AG (Germany)

 Global Health Products (US)


Table of Contents  Introduction  Research Methodology  Market Dynamics  Industry Insights  Global Oncology Nutritional Feeding Formulas Market, By Cancer Type  Product Portfolio Assessment  Company Profiles  Market Share Analysis


View Results Global Oncology Nutrition Market Contact us Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Email: poonam@bharatbook.com Follow us on


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.